Join our community!

We believe in entrepreneurship in Haifa, and invite you to share a part of our journey

STARTUPS?

Get listed

Service provider?

Join us today

Have an Event?

Submit an event

Stay updated with our news! our newsletter now

SIGN UPTO STAY IN
THE LOOP

Join our newsletter to be updated
on everything that happens in
entrepreneurship field in Haifa

Promise not to send spam!
You can unsubscribe any time

Home / Startups / Applied Immune Technologies
Applied Immune Technologies

Applied Immune Technologies

T-Cell Receptor Like Antibodies for Therapeutic Applications

Applied Immune Technologies (AIT) is a drug development company specializing in T-cell-receptor-like (TCRL) antibodies for therapeutic and diagnostic applications in a variety of cancer, viral, and autoimmune diseases. The company also focuses on identification and validation of novel therapeutic targets. AIT’s core technology platforms encompass the identification and validation of novel MHC-based targets, as well as the development of therapeutic human recombinant TCRL antibodies with the ability to bind with these intracellular peptide/MHC complexes with the specificity of cytotoxic T-cell killer cells. AIT’s technologies have the potentialto drive a pipeline of therapeutic TCRL antibodies for intracellularly derived, disease-specific targets that normally are not accessible to conventional antibodies. TCRL antibodies also have diagnostic applications in vaccine design, validation, and monitoring, as well as analysis of antigen presentation in disease.

Sectors: Pharmaceuticals

Year of establishment:

2006

Fundraising stage:

Round A

Product/Service stage:

Clinical trial

Number of employees:

51-200

Contact Applied Immune Technologies

Address

Haifa, Israel

Phone Number

No phone number
Want some more?